All In Biotech

Drug Trial Radar · NCT00003421

Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Disease

A UKLG Randomised Trial of Initial Chemotherapy for Advanced Stage Hodgkins Disease

Last checked: Nov 19, 2026Latest source record: Dec 4, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 800 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

800

Planned (sponsor's estimate)

Start

Jun 1998

Primary completion

Not stated

Study completion Nov 2005

Sponsor

Lead sponsor
Medical Research CouncilGovernment (non-federal)
Sponsor type
Government (non-federal)
First posted
Mar 12, 2004

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Primary purpose
Treatment
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known which chemotherapy regimen is more effective for advanced Hodgkin's disease. PURPOSE: Randomized phase III trial to compare different combination chemotherapy regimens in treating patients with advanced Hodgkin's disease.

Conditions

  • Lymphoma

Interventions

  • bleomycin sulfateBiological

  • ABVD regimenDrug

  • chlorambucilDrug

  • dacarbazineDrug

  • doxorubicin hydrochlorideDrug

  • etoposideDrug

  • prednisoloneDrug

  • procarbazine hydrochlorideDrug

  • vinblastine sulfateDrug

  • vincristine sulfateDrug

  • radiation therapyRadiation

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • St. James's Hospital

    Leeds, England, United Kingdom

  • Weston Park Hospital

    Sheffield, England, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.